Abstract
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed countries, characterized by the death of retinal pigment epithelial (RPE) cells and photoreceptors. Previous studies report an accumulation of damaged and dysfunctional mitochondria in RPE of human donors with AMD. Understanding how damaged mitochondria accumulate in AMD is an important step in discovering disease mechanisms and identifying therapeutic targets. In this report, we assessed mitochondrial fission and fusion by quantifying proteins and measured mitochondrial autophagy (mitophagy) via protein analysis and advanced imaging techniques using mitochondrial targeted mKeima in primary human RPE from donors with or without AMD. We report disease-specific differences in mitochondrial proteins that regulate fission, fusion, and mitophagy that were present at baseline and with treatments to stimulate these pathways. Data suggest AMD RPE utilize receptor-mediated mitophagy as a compensatory mechanism for deficits in the ubiquitin-mediated mitophagy pathway. These changes in mitochondrial homeostasis could lead to the buildup of damaged and dysfunctional mitochondria observed in the RPE of AMD donors.
Similar content being viewed by others
Introduction
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed countries. This multifactorial disease involves complex genetic and environmental factors whose effects accelerate with age1,2. AMD affects 30% of individuals 75–85 years of age, with a global estimate of 128 million cases in 2020 and 288 million cases by 2040, a consequence of the world’s increasing elderly population3,4. The two forms of AMD include “wet” and “dry”, with wet AMD caused by the abnormal growth of blood vessels into the retina. While wet AMD is less common, it has a number of effective therapies to halt or prevent vision loss5. Dry AMD is the most common form of the disease, accounting for approximately 85% of all AMD cases6. Vision loss associated with dry AMD is caused by the death of retinal pigment epithelium (RPE) and photoreceptors. RPE are essential for maintaining a healthy retina as they are responsible for key functions, such as the transport of nutrients to photoreceptors and the directed secretion of growth factors7. Currently, there are no effective treatments for dry AMD, due to our incomplete understanding of the cellular events causing disease pathology. Thus, there remains an urgent need to identify the underlying mechanisms causing AMD in order to successfully develop therapeutic interventions.
One of the prevailing hypotheses is that RPE mitochondrial defects drive AMD pathology8. This hypothesis is supported by numerous studies in human retina from eye bank donors. Analysis of electron microscopy images found donors with AMD had significantly fewer mitochondrial number, reduced surface area, and an altered cristae morphology9. Additionally, proteomic studies of human RPE tissue found an altered mitochondrial proteome, with multiple proteins in the electron transport chain decreasing in AMD RPE10,11. There are also reports of increased mitochondrial DNA damage with progression of AMD severity12,13. Consistent with the mitochondrial defects observed in tissue, cultures of human primary RPE showed significantly decreased mitochondrial function in RPE from donors with AMD14,15,16. Use of primary RPE cultures from human donors has also shown dysfunctional autophagy and increased mitochondrial damage15. Taken together, these findings suggest that mitochondrial dysfunction is a contributing factor to AMD pathology.
We tested the hypothesis that dysfunctional mitochondria accumulate in AMD due to defects in the processes that maintain a healthy mitochondrial population. We investigated three major pathways of mitochondrial homeostasis (mitochondrial fission, fusion, and mitophagy) to investigate mechanisms underlying mitochondrial dysfunction in AMD. Primary RPE cultures from donors with dry AMD (AMD) or without disease (No AMD) were treated with 2-[2-[4-(trifluoromethoxy)phenyl]hydrazinylidene]-propanedinitrile (FCCP) or cobalt chloride (CoCl2). FCCP is a mitochondrial uncoupler, leading to rapid loss of membrane potential, stimulating fission and mitophagy17. Treatment with CoCl2 was used to simulate hypoxia and induce receptor-mediated mitophagy18,19,20,21,22. Proteins that regulate pathways of mitochondrial homeostasis were quantified using immunoblotting. These measurements were coupled with live-cell imaging using mKeima-mito, a mitochondrial targeted fluorescent protein that allows for real-time monitoring of mitophagy.
In this study, we report disease-specific differences in mitochondrial proteins that regulate fission, fusion, and mitophagy that were present at baseline and with treatments that stimulate these pathways. These data suggest that changes in mitochondrial homeostasis could lead to the buildup of damaged and dysfunctional mitochondria observed in RPE of AMD donors.
Methods
Cell culture
RPE cells from de-identified donor eyes were obtained from Lions Gift of Sight (formerly known as Minnesota Lions Eye Bank) in Saint Paul, MN. Donor demographics are available in Supplementary Table 1. Donor eyes were obtained with the informed consent of the donor or donor’s family for use in medical research in accordance with the Declaration of Helsinki. Tissue handling, storage, and donor exclusion criteria are as outlined23,24. Our study utilizes donors without disease as age-matched controls and donors with dry AMD. The Minnesota Grading System (MGS) was used to classify donor eyes into No AMD (MGS1) and AMD (MGS2 and MGS3)23,24. Evaluation for MGS stages was determined by a Board Certified Ophthalmologist (Dr. Sandra R. Montezuma). Primary RPE were cultured as outlined17. Cells in passage 3 were used for all experiments. All experimental protocols were approved by the Office of Biotechnology Activities Oversight Institutional Biosafety Committee (UMN, IBC Code Number: 1706-34907H) and carried out in accordance with relevant guidelines and regulations.
RPE were treated with either 5 μM FCCP or 250 μM CoCl2. Optimal dose of FCCP was determined in a previously published methods article16. Optimal dose of CoCl2 was chosen based on preliminary experiments (Supp. Figure 9).
AAV5-mKeima-mito
Adeno-associated virus serotype 5 (AAV5) mKeima-mito was produced by the University of Minnesota Viral Vector and Cloning Core. RPE were infected, imaged, and analysis done following a previously published method17. In summary, RPE were plated at subconfluent conditions before infection with AAV5-mKeima-mito. Infection and expression efficiency reached 80% ± 10%.
Western immunoblotting
RPE were plated at confluence on Synthemax (Corning) coated 12-well plates and grown for at least 2 days before being treated with either 5 μM FCCP or 250 μM CoCl2. Cells were lysed with RIPA Buffer (Thermo Fisher) and protein concentration determined using a Bicinchoninic acid protein assay (Thermo Fisher). Protein (10 μg) was resolved on stain-free SDS-PAGE gels as described previously25. Representative immunoblots are shown (Supplementary Figs. 1–4). A table of antibodies used in this report is available in Supplementary Table 2. Data was calculated relative to protein load by using the stain free PVDF image, as well as relative to a standard protein sample included on each gel.
Statistical analysis
Fold change data was log transformed (log2) before statistical analysis. All statistical tests used an alpha of 0.05. A Grubb’s test was used to remove outliers. Normality was tested using the Shapiro–Wilk test. If data was normally distributed, an unpaired t-test was used to determine significance between AMD and No AMD. For data with a non-normal distribution, a Mann–Whitney test was used to determine significance between AMD and No AMD. To determine significance from untreated controls, a one-sample t-test or Wilcoxin signed rank test was used for normally or non-normally distributed data, respectively. mKeima-mito data (Figs. 5 and 6) was assessed using a 2-way ANOVA with treatment and disease effects and a Sidak’s multiple comparison to determine significance between No AMD and AMD RPE. Statistical analysis was performed using GraphPad Prism 9. Data presented is a mean ± SEM.
Results
Experimental design
Healthy mitochondria are maintained through a combination of fission, fusion, mitochondrial autophagy (mitophagy), and biogenesis (Fig. 1). Fission, stimulated by changing cellular conditions such as mitochondrial depolarization and oxidative stress, is required to cull damaged mitochondria from the healthy pool. Undamaged or repaired mitochondria fuse with other healthy mitochondria, increasing mitochondrial efficiency26. Damaged mitochondria are removed via mitophagy, a process that involves sequestering of target mitochondria within autophagosomes which then fuse with lysosomes where degradation occurs22. Biogenesis, while not investigated in our study, completes the circuit by supplying lipids, proteins, and DNA to replenish the mitochondrial population.
We previously characterized the use of FCCP in human primary RPE to stimulate fission and mitophagy17. Representative images of mitochondrial fragmentation and recovery after removal of FCCP are shown in Fig. 2A. Mitochondrial fission and fusion were quantified after FCCP treatment and through the recovery phase after removal of FCCP by washing cells with fresh culture media (Fig. 2B). In a separate experiment, short term and long term mitophagy responses were quantified in cells treated with FCCP or CoCl2 for up to 24 h (Fig. 2C). Proteins regulating mitochondrial homeostasis were quantified and time-lapse live-cell imaging using mKeima-mito was performed using this experimental protocol. Two main questions are addressed by our experimental design; (i) is there a treatment response relative to untreated controls and (ii) is there a difference at baseline or in response to treatment between RPE from No AMD and AMD donors?
Fission and fusion
Under conditions of mitochondrial damage and depolarization, fission proteins MFF and FIS1 recruit DRP1 to the site of fission26 (Fig. 3A). Once activated by phosphorylation, DRP1 begins to bisect the mitochondria into two pieces thereby isolating damaged mitochondria away from the healthy pool. FCCP treatment was used to stimulate fission, with lysates collected as described (Fig. 2B). Fission proteins FIS1, MFF, DRP1, and activated DRP1 (pS616-DRP1) were quantified via Western immunoblotting. Under basal conditions there was no AMD-dependent difference in content of fission proteins (Fig. 3B). After FCCP, abundance levels of FIS1 significantly increased in No AMD RPE after 72 h of recovery (p = 0.026) (Fig. 3C). For MFF, a dramatic disease-related effect was observed (Fig. 3D). While there was an overall decrease in MFF for No AMD RPE, MFF content was increased at each time point in AMD RPE. With FCCP stress, total abundance of DRP1 was significantly lower for AMD RPE (p = 0.012), which was significantly different than the response in No AMD (p = 0.020) (Fig. 3E). The content of pDRP1-S616 (an indicator of activation) relative to total DRP1 was significantly increased in No AMD and significantly decreased in AMD after 72 h recovery (Fig. 3F, p = 0.001).
In parallel with quantification of fission proteins, the fusion proteins MFN1, MFN2, and OPA1 were quantified. These three proteins lead to the fusion of both outer and inner mitochondrial membranes26(Fig. 4A). There were no significant differences in protein content for No AMD and AMD RPE under basal conditions (Fig. 4B). For MFN1, the magnitude and direction of change in content was similar for both No AMD and AMD RPE (Fig. 4C). MFN1 content was significantly lower with FCCP (No AMD, p = 0.001; AMD, p < 0.001) and at 6 h of recovery (No AMD, p = 0.028; AMD, p = 0.004) but returned to baseline by 24 h of recovery. Similar to MFN1, the content of MFN2 decreased with FCCP but returned to basal levels after 24 h of recovery (Fig. 4D). Disease-related differences include the lower MFN2 content in AMD donors after 4 h of FCCP (p = 0.043). OPA1 had both a long form (OPA1-L) and a short form (OPA1-S) visible using immunoblotting. OPA1-L promotes mitochondrial fusion while OPA1-S promotes mitochondrial fission27,28. Both bands of OPA1 were quantified separately (Supplementary Fig. 5) and reported as the ratio of OPA-L/S (Fig. 4E). Content of OPA1-L/S significantly decreased following 4 h FCCP treatment in No AMD (p = 0.014) and AMD RPE (p = 0.001) (Fig. 4E). However, RPE from No AMD donors had significantly more OPA1-L/S than AMD donors after 4 h of FCCP treatment (p = 0.039). While OPA1-L/S began to increase during the recovery time points for both groups of RPE, AMD remained significantly decreased at 24 (p = 0.027) and 72 h of recovery (p = 0.038). Taken together, these data highlight subtle disease-specific changes in fission and fusion machinery.
Quantification of mitophagy
Two main pathways of mitophagy, the ubiquitin-mediated (PINK1/Parkin) and receptor-mediated mitophagy (BNIP3, NIX) pathways were quantified (Fig. 5A). Under healthy conditions, the kinase PINK1 is degraded within the mitochondria22,29. However, under conditions of stress and depolarization, PINK1 remains in the outer mitochondrial membrane and activates PARKIN, an E3-ubiquitin ligase. PARKIN then adds a specific phosphorylated ubiquitin (pS65-Ubiquitin) to outer mitochondrial membrane proteins, leading to degradation by the proteasome and initiation of mitophagy. Receptor-mediated mitophagy proteins NIX and BNIP3 can be activated by PINK1, as well as conditions of hypoxia and other stressors22. Upon activation, NIX and BNIP3 directly interact with autophagosomes through p62 and LC3, without ubiquitin, to initiate mitophagy.
We quantified cellular autophagy markers (LC3 and p62), as well as proteins from ubiquitin-mediated mitophagy (PINK, Parkin, and pS65-Ubiquitin (pS65-Ub)) and receptor-mediated mitophagy (Nix and BNIP3) (Fig. 5A). Under basal conditions, AMD RPE had ~ 50% less PINK content (p = 0.015) (Fig. 5B). Treatment with FCCP had no effect on p62 but led to an approximate eightfold increase in LC3-II / LC3-I content, an indication that cellular autophagy is robustly increased in both No AMD and AMD RPE (Fig. 5C). While there were no significant differences in PINK1 or pS65-Ubiquitin content after FCCP, Parkin content was significantly decreased in both groups (No AMD, p = 0.007; AMD, p < 0.001) but was significantly lower in AMD RPE (p = 0.015) (Fig. 5D). The receptor-mediated proteins were also quantified, with AMD RPE having significantly decreased NIX content compared with No AMD RPE (p = 0.040). Both No AMD (p = 0.002) and AMD (p = 0.029) had significantly decreased BNIP3 content (Fig. 5E). To assess the effects of sustained FCCP on mitophagy proteins, we also quantified proteins after 24 h of FCCP (Supplementary Fig. 6). Nearly all proteins returned to basal levels, indicating both cellular autophagy and mitophagy had slowed relative to the four hour treatment data. This response agrees with previously published findings that membrane potential returns to baseline at 24 h FCCP treatment17.
To determine if the disease-dependent differences in mitophagy machinery have functional effects, we quantified cellular mitophagy using mKeima-mito. A recent publication from our laboratory provides a detailed summary of the quantification of mitophagy using mKeima-mito17. Briefly, mKeima is a fluorescent protein that shifts excitation wavelengths based on pH of the local environment. Mitochondria in the cytoplasm are in a neutral pH environment, but upon fusion with the lysosome are contained within an acidic environment. This change in local pH during mitophagy allows for the imaging of mKeima using two fluorescent channels. Fusing mKeima to a mitochondrial targeting sequence allows for mitophagy to be quantified as a ratio of neutral (green) cytoplasmic mitochondria to acidic (red) lysosomal mitochondria. Representative images of primary RPE expressing mKeima-mito treated with FCCP are shown (Fig. 5F). Individual neutral (green) and acidic (red) channels for both No AMD and AMD RPE treated with FCCP are shown (Supplementary Fig. 7).
Treatment with FCCP leads to fragmentation of mitochondria and induction of mitophagy, as seen as an increase in acidic (red) and slight decrease in neutral (green) traces (Fig. 5G). After calculating the ratio of acidic to neutral mitochondria, an increase in mitophagy is visualized as an increase in the ratio (Fig. 5H). This ratio shows FCCP treatment induced a significant increase in mitophagy for both No AMD and AMD RPE (p = 0.001). Of note, AMD RPE were consistently lower at each time point than No AMD RPE (~ 6–18%), suggesting a slight decrease in mitophagy, though this difference was not statistically significant.
In addition to FCCP treatment, RPE were treated with FCCP and had chloroquine (CQ) added 2 h before lysis to prevent autophagosome and lysosomal fusion30. Treatment with CQ prevents autophagosome-lysosomal fusion, effectively stalling cellular autophagy (Mauthe et al.31). This allows for quantification of autophagy flux, an important control to include when cellular autophagy is very rapid. Overall, the results from FCCP treatment with and without CQ provided similar answers except for the results for BNIP3 (Supplementary Fig. 8). BNIP3 content was increased in No AMD RPE relative to FCCP alone, and was significantly different than AMD RPE (p = 0.016).
Cobalt chloride and mitochondrial homeostasis
As AMD RPE had significant differences in receptor-mediated mitophagy proteins in response to FCCP, we wanted to further investigate these pathways. Additionally, FCCP causes rapid depolarization of the mitochondrial membrane and therefore is not physiologically relevant to AMD disease mechanisms. Receptor-mediated mitophagy proteins, BNIP3 and Nix, are activated by hypoxia32. To stimulate receptor-mediated mitophagy with a more physiologically relevant stress, we simulated hypoxia via HIF1α stabilization with cobalt chloride (CoCl2). To determine optimal dose, we measured cell viability and mitochondrial membrane potential (Supplementary Fig. 9). As the goal of this treatment was to induce a mitochondrial stress response without cell death, we chose a dose of 250 μM CoCl2.
CoCl2 treatment led to an expected increase in HIF1α content at 12 and 24 h in RPE irrespective of disease status (Fig. 6A). Treatment also led to a significant upregulation of autophagy, as indicated by the increased content of LC3-II/I in both No AMD and AMD RPE at 12 (No AMD, p = 0.021; AMD, p = 0.080) and 24 h (No AMD, p = 0.036; AMD, p = 0.041) (Fig. 6B). We quantified a panel of proteins involved in mitochondrial homeostasis and found significantly increased content of BNIP3 in No AMD RPE at 12 (p = 0.0204) and 24 h (p = 0.012) treatment (Fig. 6C). RPE from AMD donors had a significant increase in BNIP3 at 12 h (p = 0.044) but not 24 h (p = 0.066). There were no significant changes in Nix, MFN2, or PINK1 (Fig. 6D–F). As with FCCP experiments, CQ was included to assess autophagy flux (Supplementary Fig. 10). Control experiments with CQ did not show any significant results between RPE from No AMD and AMD donors. RPE expressing mKeima-mito were imaged after treatment with CoCl2 for up to 24 h. We observed a slight increase in mitophagy in both No AMD and AMD RPE after CoCl2 treatment (Fig. 6G + H). Individual neutral (green) and acidic (red) channels for both No AMD and AMD RPE treated with FCCP are shown (Supplementary Fig. 11). While not significantly different, AMD RPE had a larger increase in mitophagy by 24 h (~ 8%) (Fig. 6I). These results indicate that 250 µM CoCl2 stabilized HIF1α as expected, while leading to a mild increase in cellular autophagy and mitophagy in RPE. However, these results were similar between RPE from No AMD and AMD donors.
Discussion
In this study, we investigated mitochondrial fission, fusion, and mitophagy in human primary RPE cultures to determine if defects in these pathways lead to the accumulation of damaged and dysfunctional mitochondria associated with AMD (Fig. 1). To investigate these pathways of mitochondrial homeostasis, treatments of FCCP and CoCl2 were used to stimulate mitophagy via rapid membrane depolarization and hypoxia simulation, respectively. Our results show an AMD-specific response to FCCP-induced stress in fission, fusion, and mitophagy proteins. Additionally, content of PINK1 was significantly lower in RPE from AMD donors under basal conditions. After treatment with CoCl2, RPE from both No AMD and AMD donors had similar increases in autophagy and mitophagy.
Previous investigations of mitochondrial morphology in RPE tissue samples and primary cultures found decreased mitochondrial surface area, indicative of mitochondrial fragmentation9,15. Additionally, a recent study reported decreased mitochondrial volume in AMD donor tissue samples33. In support of these results, we observed changes in the fission and fusion pathways that may lead to increased mitochondrial fragmentation in AMD. Of the fission proteins investigated, MFF had the most significant changes in response to FCCP-induced stress (Fig. 3D). Notably, the change in MFF content was in opposing directions for No AMD and AMD RPE, with No AMD RPE decreasing content and AMD RPE increasing MFF content in response to stress. Previous investigation of MFF overexpression found that increased MFF content led to an increase in mitochondrial fission34. In contrast, MFF mutants with decreased MFF activity have been associated with a reduction of fission34. These results suggest that the increase in MFF content observed in AMD RPE could lead to increased mitochondrial fission.
Additionally, treatment with FCCP led to a significant decrease in all three mitochondrial fusion proteins in both No AMD and AMD RPE (Fig. 4). Decreasing content of fusion proteins is a mechanism utilized by cells under stress to prevent mitochondrial fusion. MFN1 and MFN2 content, as well as OPA1 cleavage, occurs when the mitochondrial membrane potential decreases to prevent fusion, and the mitochondria attempts to undergo either repair or mitophagy26. While the RPE from No AMD and AMD donors had similar directional responses in all three fusion proteins investigated, there was an overall decreased content in AMD RPE. Additionally, AMD RPE were consistently delayed in their recovery in the fusion proteins investigated. These results may indicate that AMD RPE have an increased response to stress, leading to increased fragmentation and a delayed ability to undergo fusion. These data are consistent with previous reports of decreased mitochondrial surface area and altered mitochondrial morphology in AMD RPE tissue, which are isolated from a diseased environment where mitochondria may be under stress9.
Previous studies utilizing starvation and oxidative stress found decreased autophagy in RPE of AMD donors that may prevent adequate removal of damaged mitochondria15,35. While these studies provided an assessment of cellular autophagy, our study is the first to investigate mitophagy in human primary RPE from donors with AMD. We observed significant differences in mitophagy pathways at baseline and after FCCP treatment (Fig. 5). Under basal conditions, we observed an approximate 50% decrease in PINK1 content in RPE from AMD donors (Fig. 5B). Numerous studies using a human neuroblastoma cell line report that decreased PINK1 content led to increased mitochondrial fragmentation, and cell death36,37,38. Decreased PINK1 content in the RPE from AMD donors may contribute to increased mitochondrial fragmentation and loss of RPE observed in past experiments using human RPE tissue and the fission and fusion experiments conducted in this report.
After FCCP treatment, PINK1 content was similar in RPE from No AMD and AMD donors but content of Parkin was significantly lower in AMD RPE. This decrease in Parkin content following FCCP treatment may stem from lower PINK1 content under basal conditions, as PINK1 is a sensor of mitochondrial depolarization and activator of Parkin26,39. In addition to differences in ubiquitin-mediated mitophagy, receptor-mediated proteins were significantly decreased in RPE from AMD donors following FCCP-induced stress (Fig. 5E). While not significant, when quantifying mitophagy via mKeima-mito, we observed consistently decreased mitophagy over time in the AMD RPE. Together, these results suggest a decreased capacity for AMD RPE to induce and conduct mitophagy in response to FCCP. The increased fission response and delayed fusion response of AMD RPE, combined with these findings of reduced mitophagy, could lead to the accumulation of damaged mitochondria in AMD.
Due to the significant differences in both ubiquitin-mediated and receptor-mediated mitophagy proteins after FCCP induced stress, we further investigated these pathways by using CoCl2. Treatment with CoCl2 stabilizes HIF1α, inducing the hypoxia response, which activates receptor-mediated mitophagy32. While not significant, we observed consistently increased mitophagy in RPE from AMD donors after treatment with CoCl2. Previous reports of PINK1 or PARKIN knockouts have shown that receptor-mediated pathways are able to compensate in order to maintain mitophagy36,40. Our results after CoCl2 induced stress, combined with the significant decrease in basal PINK1 and decreased PARKIN content after FCCP treatment, suggest that AMD RPE may utilize receptor-mediated mitophagy as a compensatory mechanism for deficits in the ubiquitin-mediated mitophagy pathway.
One limitation of our study is the use of whole cell lysates to investigate mitochondrial proteins. Many mitochondrial proteins are encoded by the nuclear DNA and imported into the mitochondria, and therefore dependent on localization to the mitochondria to be active. By using whole cell lysates, we are unable to determine if a change in protein content is reflective of a change in mitochondrial localization and activity. Protocols exist for mitochondrial isolation from cells, but this technique is not possible in primary RPE due to the limited cell numbers generated from a human donor. Future studies investigating protein localization and activation could further utilize immunofluorescent labeling and mitochondrial imaging to determine localization of these proteins. Additionally, imaging experiments using high resolution microscopy would allow for the measurement of mitochondrial length and volume, providing insight into time dependent mitochondrial fission and fusion dynamics. Another limitation is that we did not investigate biogenesis, the expansion of mitochondria via increased lipid and protein production, and mtDNA replication. Investigating biogenesis presents challenges, including the requirement of methods to deplete mitochondria in order to monitor activation of these pathways. Future studies into mitochondrial regulation and mitochondrial homeostasis are required to further understand how defects in these pathways may lead to an AMD phenotype.
There are several caveats to consider when using human primary RPE cultures, including the difficulty in acquiring samples, limited cell numbers, and donor-to-donor variability. Additionally, primary RPE are cultured from the donor eyes of individuals age 60 years or older, and in the case of an AMD donor, have been living and surviving in the diseased retina. It is possible that only the healthiest cells are able to survive our culture conditions, thereby limiting our ability to assess the full range of defects present in the RPE of AMD donors. This idea is supported by the increased resistance of AMD RPE to peroxide-induced stress, suggesting these cells have been preconditioned to handle stress14.
The observed response to FCCP-induced stress highlights potential defects in mitochondrial homeostasis that may contribute to the death of RPE in AMD. Previous studies of AMD RPE graded for disease severity have observed an accumulation of mitochondrial damage and dysfunction that begins early in disease2,9,10,11,13,14,23,41,42,43. Current models of AMD pathogenesis center on metabolic uncoupling, in which defects in RPE mitochondria lead to the starvation of photoreceptors8,44. Since RPE rely on photoreceptors for various nutrients, this starvation begins a cycle of escalating metabolic changes that culminates in the death of RPE and photoreceptors leading to vision loss8.
The central role of mitochondria in RPE health and development of AMD has led to a number of studies testing the efficacy of mitochondrial targeted drugs. For example, the tetrapeptide SS-31 targets mitochondrial cardiolipin, which is crucial for maintaining mitochondrial oxidative phosphorylation, is being investigated in a phase 2 clinical trial for dry AMD45. The antidiabetic drug metformin has been shown to activate AMPK, promoting mitochondrial biogenesis. A recent study of over 7000 diabetic patients taking metformin found that metformin treatment was linked to reduced risk for AMD46. Additional compounds designed to protect mitochondria from oxidative damage (N-acetyl-L-Cysteine; NAC), remove damaged mitochondria via increased autophagy (rapamycin), upregulate mitochondrial biogenesis (pyrroloquinoline; PQQ), or improve oxidative phosphorylation (nicotinamide mononucleotide, NMN) have been investigated in our lab47. We found that RPE from AMD donors responded to the drugs as detected by the increase in mitochondrial function. In contrast, RPE from donors without AMD did not respond to the drugs. These results are consistent with the idea that mitochondrial dysfunction in the diseased cells can be ameliorated by treatments that target mitochondrial defects. Our study supports the idea that mitochondrial defects drive AMD, and targeting pathways of mitochondrial homeostasis may be a viable treatment option.
This study uncovers potential mechanisms leading to mitochondrial damage and dysfunction associated with AMD that may initiate the metabolic crisis in the retina. We observed disease-specific differences under basal conditions and in response to two mitochondrial stressors, FCCP and CoCl2. The AMD-associated changes in mitochondrial proteins reported in this study could lead to the buildup of damaged and dysfunctional mitochondria that begins to disrupt the delicate retinal ecosystem and lead to the eventual death of RPE and photoreceptors in AMD. Experiments using different stressors and analytical methods may further identify mechanisms that explain these AMD-associated changes in mitochondrial homeostasis, providing new therapeutic targets to treat AMD.
Data availability
All data generated or analyzed during this study are included in this published article (and its Supplementary Information files).
References
Bowes Rickman, C., Farsiu, S., Toth, C. A. & Klingeborn, M. Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging. Invest. Opthalmol. Visual Sci. 54, ORSF68 (2013).
Kaarniranta, K. et al. Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog. Retin. Eye Res. 79, 100858 (2020).
Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106–e116 (2014).
Leibowitz, H. M. et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv. Ophthalmol. 24, 335–610.
Treatments for Wet AMD (Advanced Neovascular AMD) | National Eye Institute. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration/wet-amd-type-late-age-related-macular-degeneration-read-about-treatments-wet-amd-anti-vegf.
Seddon, J. M. & Chen, C. A. The epidemiology of age-related macular degeneration. Int. Ophthalmol. Clin. 44, 17–39 (2004).
Strauss, O. The retinal pigment epithelium in visual function. Physiol. Rev. 85, 845–881 (2005).
Fisher, C. R. & Ferrington, D. A. Perspective on AMD Pathobiology: A Bioenergetic Crisis in the RPE. Invest. Opthalmol. Visual Sci. 59, AMD41 (2018).
Feher, J. et al. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging 27, 983–993 (2006).
Nordgaard, C. L., Karunadharma, P. P., Feng, X., Olsen, T. W. & Ferrington, D. A. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest. Opthalmol. Visual Sci. 49, 2848 (2008).
Nordgaard, C. L. et al. Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest. Opthalmol. Visual Sci. 47, 815 (2006).
Ferrington, D. A. et al. Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration. Exp. Eye Res. 145, 269–277 (2016).
Karunadharma, P. P., Nordgaard, C. L., Olsen, T. W. & Ferrington, D. A. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest. Opthalmol. Visual Sci. 51, 5470 (2010).
Ferrington, D. A. et al. Altered bioenergetics and enhanced resistance to oxidative stress in human retinal pigment epithelial cells from donors with age-related macular degeneration. Redox Biol. 13, 255–265 (2017).
Golestaneh, N., Chu, Y., Xiao, Y. Y., Stoleru, G. L. & Theos, A. C. Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration. Cell Death Dis. 8, (2017).
Cano, M. et al. Nrf2 deficiency decreases NADPH from impaired IDH shuttle and pentose phosphate pathway in retinal pigmented epithelial cells to magnify oxidative stress‐induced mitochondrial dysfunction. Aging Cell 20, (2021).
Fisher, C. R., Ebeling, M. C. & Ferrington, D. A. Quantification of mitophagy using mKeima-mito in cultured human primary retinal pigment epithelial cells. Exp. Eye Res. 217, 108981 (2022).
Zhang, W. et al. Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I/R heart injury. Elife 5, (2016).
Yu, Y. et al. Inhibition of autophagy enhanced cobalt chloride-induced apoptosis in rat alveolar type II epithelial cells. Mol. Med. Rep. https://doi.org/10.3892/mmr.2018.9209 (2018).
Chen, R. et al. Effects of cobalt chloride, a hypoxia-mimetic agent, on autophagy and atrophy in skeletal C2C12 myotubes. Biomed. Res. Int. 2017, 1–9 (2017).
He, Y. et al. CoCl2 induces apoptosis via a ROS-dependent pathway and Drp1-mediated mitochondria fission in periodontal ligament stem cells. Am. J. Physiol. Cell Physiol. 315, C389–C397 (2018).
Wei, H., Liu, L. & Chen, Q. Selective removal of mitochondria via mitophagy: distinct pathways for different mitochondrial stresses. Biochimica et Biophysica Acta (BBA)—Mol. Cell Res. 1853, 2784–2790 (2015).
Decanini, A., Nordgaard, C. L., Feng, X., Ferrington, D. A. & Olsen, T. W. Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. Am. J. Ophthalmol. 143, 607-615.e2 (2007).
Olsen, T. W. & Feng, X. The minnesota grading system of eye bank eyes for age-related macular degeneration. Invest. Opthalmol. Visual Sci. 45, 4484 (2004).
Ebeling, M. C. et al. Impaired mitochondrial function in iPSC-retinal pigment epithelium with the complement factor H polymorphism for age-related macular degeneration. Cells 10, 789 (2021).
Tilokani, L., Nagashima, S., Paupe, V. & Prudent, J. Mitochondrial dynamics: Overview of molecular mechanisms. Essays Biochem. 62, 341–360 (2018).
del Dotto, V., Fogazza, M., Carelli, V., Rugolo, M. & Zanna, C. Eight human OPA1 isoforms, long and short: What are they for?. Biochim Biophys Acta Bioenerg 1859, 263–269 (2018).
del Dotto, V. et al. OPA1 isoforms in the hierarchical organization of mitochondrial functions. Cell Rep. 19, 2557–2571 (2017).
Twig, G. & Shirihai, O. S. The interplay between mitochondrial dynamics and mitophagy. Antioxidants and Redox Signaling 14 (2011).
Yoon, Y. H. et al. Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells. Invest. Ophthalmol. Visual Sci. 51, (2010).
Mauthe M, Orhon I, Rocchi C et al. Chloroquine inhitis autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14(8), 1435–1455.
Wu, H. & Chen, Q. Hypoxia activation of mitophagy and its role in disease pathogenesis. Antioxid. Redox Signal. 22, 1032–1046 (2015).
la Cunza, N. et al. Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration. JCI Insight 6, (2021).
Otera, H. et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191, 1141–1158 (2010).
Mitter, S. K. et al. Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy 10, (2014).
Parganlija, D. et al. Loss of PINK1 impairs stress-induced autophagy and cell survival. PLoS ONE 9, e95288 (2014).
Lutz, A. K. et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J. Biol. Chem. 284, 22938–22951 (2009).
Dagda, R. K. et al. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 284, 13843–13855 (2009).
Xiao, B. et al. Reactive oxygen species trigger Parkin/PINK1 pathway–dependent mitophagy by inducing mitochondrial recruitment of Parkin. J. Biol. Chem. 292, (2017).
Koentjoro, B., Park, J.-S. & Sue, C. M. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson’s disease. Sci. Rep. 7, 44373 (2017).
Ferrington, D. A., Fisher, C. R. & Kowluru, R. A. Mitochondrial defects drive degenerative retinal diseases. Trends Mol. Med. 26 (2020).
Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W. & Ferrington, D. A. The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest. Opthalmol. Visual Sci. 47, 2280 (2006).
Terluk, M. R. et al. Investigating mitochondria as a target for treating age-related macular degeneration. J. Neurosci. 35, 7304–7311 (2015).
Kanow, M. A. et al. Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye. Elife 6, (2017).
ReCLAIM-2 study to evaluate safety, efficacy & pharmacokinetics of elamipretide in subjects with AMD With Non-central GA - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03891875.
Brown, E. E. et al. The common antidiabetic drug metformin reduces odds of developing age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 60, 1470–1477 (2019).
Ebeling, M. C. et al. Improving retinal mitochondrial function as a treatment for age-related macular degeneration. Redox. Biol. 34, 101552 (2020).
Acknowledgements
The authors wish to acknowledge the contribution of personnel from the Lions Gift of Sight (St. Paul, MN) for their assistance in procuring human donor eyes and processing eye tissue. The authors also thank the donors and their families for their essential contributions to the research. This work was supported in part by the National Institutes of Health (NIH) National Eye Institute (NEI) F31-EY031558 (to CRF), T32-EY025187 (to CRF), R01EY026012 (to DAF), and R01EY028554 (to DAF), NIH National Institute of Aging (NIA) T32-AG029796 (to CRF), Diana Jacobs Kalman/AFAR Scholarships for Research in the Biology of Aging (to CRF), VitreoRetinal Surgery Foundation Fellowship (to CRF), University of Minnesota Undergraduate Research Opportunities Program (to AAS), the Elaine and Robert Larson Endowed Vision Chair, the Lindsay Family Foundation, and an anonymous benefactor for AMD research.
Author information
Authors and Affiliations
Contributions
Conceptualization: C.R.F., A.A.S., D.A.F.; Methodology: C.R.F., A.A.S., M.C.E., D.A.F.; Investigation: C.R.F., A.A.S., M.C.E., S.R.M.; Writing—Original Draft: C.R.F.; Writing—Review and Editing: C.R.F., A.A.S., M.C.E., S.R.M., D.A.F.; Supervision: C.R.F. and D.A.F.; Funding Acquisition: C.R.F. and D.A.F.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fisher, C.R., Shaaeli, A.A., Ebeling, M.C. et al. Investigating mitochondrial fission, fusion, and autophagy in retinal pigment epithelium from donors with age-related macular degeneration. Sci Rep 12, 21725 (2022). https://doi.org/10.1038/s41598-022-26012-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-26012-5
- Springer Nature Limited
This article is cited by
-
Urolithin A promotes p62-dependent lysophagy to prevent acute retinal neurodegeneration
Molecular Neurodegeneration (2024)